HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse Reactions

NCT03184597 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

4000

Enrollment

OTHER

Sponsor class

Conditions

Epilepsy
Neuropathy
Psychiatric Illness
Blepharospasm

Interventions

DIAGNOSTIC_TEST: HLA screening before commencing aromatic AEDs

Sponsor

Second Affiliated Hospital of Guangzhou Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]